Work

A phase II trial of oxaliplatin, docetaxel, and bevacizumab as first-line therapy of advanced cancer of the ovary, peritoneum, and fallopian tube

Year: 2014

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2014.01.035

Authors: Thomas J. Herzog, Bradley J. Monk, Peter G. Rose, Patricia Braly, Jeffrey F. Hines, Maria C. Bell, Robert M. Wenham, Angeles Alvarez Secord, Lynda D. Roman, Mark H. Einstein, Richard D. Drake, Barrett H. Childs

Institutions: Columbia University Irving Medical Center, Columbia University, Creighton University, St. Joseph's Hospital and Medical Center, Cleveland Clinic, Sioux Valley Hospital, Moffitt Cancer Center, Duke Medical Center, Duke Cancer Institute, USC Norris Comprehensive Cancer Center, Albert Einstein College of Medicine, Montefiore Medical Center, Sanofi (United States)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Sanofi, Genentech, National Cancer Institute

Award: Moffitt Cancer Center Support Grant

OpenAlex ID: W2010108166

FWCI: 4.849

Cites: 23

Cited by: 23

Related to: 10